Genital ulcer diseases as an entry for HIV infection;Owrzodzenia narza̧dów płciowych jako wrota do zakażenia wirusem HIV

Postepy Dermatologii i Alergologii

Volumn 26, Issue 4, 2009, Pages 206-211

  Duş, Monika ^a   Łuczkowska, Magdalena ^a   Zaba, Ryszard ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Genital ulcers; HIV

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

CELL COUNT; CELL SURFACE; DISEASE ASSOCIATION; GENITAL ULCER; HAEMOPHILUS DUCREYI; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLAMMATORY INFILTRATE; MACROPHAGE; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL BEHAVIOR; SKIN INJURY; SYPHILIS; T LYMPHOCYTE; TREPONEMA PALLIDUM; ULCUS MOLLE; VIRUS ENTRY; VIRUS TRANSMISSION;

EID: 70449629361     PISSN: 1642395X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (62)

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3-17.
2. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet 1989; 2: 403-407
3. Plummer FA, Simonsen JN, Cameron DW, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163: 233-239
4. Wasserheit JN. Epidemiological synergy. Interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex Transm Dis 1992; 19: 61-77.
5. Da Costa JB, Domingues D, Castro R, Exposto F. Genital ulcers caused by sexually transmitted diseases: current therapies, diagnosis and their relevance in HIV pandemy. Acta Med Port 2006; 19: 335-342 (Pubitemid 47233600)
6. Jessamine PG, Plummer FA, Ndinya Achola JO, et al. Human immunodeficiency virus, genital ulcers and the male foreskin: synergism in HIV-1 transmission. Scand J Infect Dis Suppl 1990; 69: 181-186 (Pubitemid 20333104)
7. Dickerson MC, Johnston J, Delea TE, et al. The causal role for genital ulcer disease as a risk factor for transmission of human immunodeficiency virus. An application of the Bradford Hill criteria. Sex Transm Dis 1996; 23: 429-440
8. Rompalo AM, Shepherd M, Lawlor JP, et al. Definitions of genital ulcer disease and variation in risk for prevalent human immunodeficiency virus infection. Sex Transm Dis 1997; 24: 436-442 (Pubitemid 27452572)
9. Quinn TC. Association of sexually transmitted diseases and infection with the human immunodeficiency virus: biological cofactors and markers of behavioral interventions. Int J STD AIDS 1996; 7 (Suppl 2): 17-24. (Pubitemid 26189536)
10. Morse SA. Etiology of genital ulcer disease and its relationship to HIV infection. Sex Transm Dis 1999; 26: 63-65 (Pubitemid 29031647)
11. Clottey C, Dallabetta G. Sexually transmitted diseases and human immunodeficiency virus, epidemiologic synergy? Infect Dis Clin North Am 1993; 7: 753-770
12. Hayes RJ, Schulz KF, Plummer FA. The cofactor effect of genital ulcers on the per-exposure risk of HIV transmission in sub- Saharan Africa. J Trop Med Hyg 1995; 98: 1-8.
13. Mastro TD, de Vincenzi I. Probabilities of sexual HIV-1 transmission. AIDS 1996; 10 Suppl A: S75-82.
14. Mastro TD, Satten GA, Nopkesorn T, et al. Probability of female- to-male transmission of HIV-1 in Thailand. Lancet 1994; 343: 204-207 (Pubitemid 24031642)
15. Moore EA, Moore LM. Herpes simplex virus. In: Moore EA, Moore LM. Encyclopedia of Sexually Transmitted Diseases. McFarland 2004; 137-138
16. Bruisten SM. Genital ulcers in women. Curr Womens Health Rep 2003; 3: 288-298
17. LeGoff J, Weiss HA, Gresenguet G, et al. Cervicovaginal HIV-1 and herpes simplex virus type 2 shedding during genital ulcer disease episodes. AIDS 2007; 12: 1569-1578
18. Freeman EE, Weiss HA, Glynn JR, et al. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20: 73-83.
19. Wald A, Link K. Risk of human immunodeficiency virusinfection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185: 45-52. (Pubitemid 34043015)
20. Nagot N, Ouedraogo A, Konate I, et al.; ANRS 1285 Study Group. Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels. J Infect Dis 2008; 198: 241-249 (Pubitemid 352035760)
21. Risbud A, Chan-Tack K, Gadkari D, et al. The etiology of genital ulcer disease by multiplex polymerase chain reaction and relationship to HIV infection among patients attending sexually transmitted disease clinics in Pune, India. Sex Transm Dis 1999; 26: 55-62. (Pubitemid 29031646)
22. Chen CY, Ballard RC, Beck-Sague CM, et al. Human immunodeficiency virus infection and genital ulcer disease in South Africa: the herpetic connection. Sex Transm Dis 2000; 27: 21-29 (Pubitemid 30058900)
23. Schacker T, Ryncarz AJ, Goddard J, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280: 61-66 (Pubitemid 28414998)
24. Cowan FM, Humphrey JH, Ntozini R, et al. Maternal Herpes simplex virus type 2 infection, syphilis and risk of intra-partum transmission of HIV-1: results of a case control study. AIDS 2008; 2: 193-201.
25. World Health Organization. Guidelines for the management of sexually transmitted infections. WHO, Geneva, Switzerland; 2003.
26. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 2109-2119 (Pubitemid 351902179)
27. Mroczkowski TF, Martin DH. Kiła. W: Choroby przenoszone droga̧ płciowa̧. Mroczkowski TR (red.). Wydawnictwo Medyczne PZWL, Warszawa 1998; 215-285
28. Corona R, Caprilli F, Tosti ME, et al. Risk of human immunodeficiency virus infection and genital ulcer disease among persons attending a sexually transmitted disease clinic in Italy. Epidemiol Infect 1998; 121: 623-630 (Pubitemid 29023041)
29. Hanson J, Posner S, Hassig S, et al. Assessment of sexually transmitted diseases as risk factors for HIV seroconversion in a New Orleans sexually transmitted disease clinic, 1990-1998. Ann Epidemiol 2005; 15: 13-20.
30. Pépin J, Quigley M, Todd J, et al. Association between HIV-2 infection and genital ulcer diseases among male sexually transmitted disease patients in The Gambia. AIDS 1992; 5: 489-493
31. Ballard RC, Koornhof HJ, Chen CY, et al. The influence of concomitant HIV infection on the serological diagnosis of primary syphilis in southern Africa. S Afr Med J 2007; 97: 1151-1154
32. Leber A, MacPherson P, Lee BC. Epidemiology of infectious syphilis in Ottawa. Recurring themes revisited. Can J Public Health 2008; 99: 401-405
33. Duś M. Wrzód miȩkki - obraz kliniczny, współczesna epidemiologia, diagnostyka i leczenie. Post Dermatol Alergol 2008; 25: 76-82. (Pubitemid 351795846)
34. MacDonald KS, Malonza I, Chen DK, et al. Vitamin A and risk of HIV-1 seroconversion among Kenyan men with genital ulcers. AIDS 2001; 15: 635-639 (Pubitemid 32281360)
35. Telzak EE, Chiasson MA, Bevier PJ, et al. HIV-1 seroconversion in patients with and without genital ulcer disease. A prospective study. Ann Intern Med 1993; 119: 1181-1186
36. Piot P, Laga M. Genital ulcers, other sexually transmitted diseases, and the sexual transmission of HIV. BMJ 1989; 298: 623-624
37. Greenblatt RM, Lukehart SA, Plummer FA, et al. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS 1988; 2: 47-50.
38. Sheffield JS, Wendel GD Jr, McIntire DD, Norgard MV. Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract. J Infect Dis 2007; 196: 1509-1516
39. Arora PN, Sastry CV. HIV infection and genital ulcer disease. Indian J Sex Transm Dis 1992; 13: 71-73.
40. Humphreys TL, Schnizlein-Bick CT, Katz BP, et al. Evolution of the cutaneous immune response to experimental Haemophilus ducreyi infection and its relevance to HIV-1 acquisition. J Immunol 2002; 169: 6316-6323
41. Engelkens HJ, ten Kate FJ, Judanarso J, et al. The localization of treponemas and characterization of the inflammatory infiltrate in skin biopsies from patients with primary or secondary syphilis, or early infectious yaws. Genitourin Med 1993; 69: 102-107
42. McBroom RL, Styles AR, Chiu MJ, et al. Secondary syphilis in persons infected with and not infected with HIV-1. Am J Dermatopathol 1999; 21: 432-441
43. Dragic T, Litwin V, Allaway GP, et al. HIV-1 entry into CD4-cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996; 381: 667-673
44. Maddon PJ, Dalgleish AG, McDougal JS, et al. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 1986; 47: 333-348
45. Holmes KK, Sparling PF, Mårdh PA, et al. Immunology of human immunodeficiency virus. Sexually transmitted diseases. McGraw-Hill, New York 1999; 231-249
46. Qin S, Rottman JB, Myers P, et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746-754 (Pubitemid 28096070)
47. Campbell JJ, Brightling CE, Symon FA, et al. Expression of chemokine receptors by lung T cells from normal and asthmatic subjects. J Immunol 2002; 166: 2842-2848
48. Choe H, Farzan M, Sun Y, et al. The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell 1996; 85: 1135-1148 (Pubitemid 26231178)
49. Deng H, Liu R, Ellmeier W, et al. Identification of a major coreceptor for primary isolates of HIV-1. Nature 1996; 381: 661-666 (Pubitemid 26197679)
50. Anderson DJ, Fichorova R, Haimovici F, et al. B-chemokines and their receptors in the lower female genital tract. J Soc Gynecol Investig 1997; 4: 201A.
51. Rottman JB, Ganley KP, Williams K, et al. Cellular localization of the chemokine receptor CCR5: correlation to cellular targets of HIV-1 infection. Am J Pathol 1997; 151: 1341-1351 (Pubitemid 27479764)
52. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med 1997; 185: 1681-1691 (Pubitemid 27203264)
53. Bleul CC, Wu L, Hoxie JA, et al. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes. Proc Natl Acad Sci USA 1997; 94: 1925-1930 (Pubitemid 27113938)
54. Huang Y, Paxton WA, Wolinsky SM, et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat Med 1996; 2: 1240-1243 (Pubitemid 26375409)
55. Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 1996; 382: 722-725
56. Dean M, Carrington M, Winkler C, et al. Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study. Science 1996; 273: 1856-1862
57. Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection. Cell 1996; 86: 367-377 (Pubitemid 26272077)
58. Sellati TJ, Bouis DA, Kitchens RL, et al. Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that utilized by lipopolysaccharide. J Immunol 1998; 160: 5455-5464
59. Theus SA, Harrich DA, Gaynor R, et al. Treponema pallidum, lipoproteins, and synthetic lipoprotein analogues induce human immunodeficiency virus type 1 gene expression in monocytes via NF-kappaB activation. J Infect Dis 1998; 177: 941-950 (Pubitemid 28155146)
60. Sellati TH, Wilkinson DA, Sheffield JS, et al. Virulent treponema pallidum, lipoprotein, and synthetic lipopeptides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus type 1. J Infect Dis 2000; 181: 283-293
61. Sellati TJ, Waldrop SL, Salazar JC, et al. The cutaneous response in humans to Treponema pallidum lipoprotein analogues involves cellular elements of both innate and adaptive immunity. J Immunol 2001; 166: 4131-4140
62. Ryszard Żaba. Ocena stanu immunologicznego osób zakażonych HIV. Seksuologia 1995; 17: 21-29